259 related articles for article (PubMed ID: 9657124)
1. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
Sudan D; Sudan R; Schafer D; Langnas A
Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
[No Abstract] [Full Text] [Related]
2. Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.
Duvoux C; Cherqui D; Van Nhieu JT; Vavasseur D; Zafrani ES; Mathieu D; Fagniez PL; Dhumeaux D
Transplant Proc; 1994 Dec; 26(6):3572-3. PubMed ID: 7527981
[No Abstract] [Full Text] [Related]
3. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
Chen M; Li J; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
[TBL] [Abstract][Full Text] [Related]
4. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma with cirrhosis: the initial experience and a preliminary report from the University of Ghent, Belgium.
Troisi R; Praet M; Defreyne L; Elewaut A; Hesse UJ; Pattyn P; Decruyenaere J; De Hemptinne B
Transplant Proc; 1994 Dec; 26(6):3570-1. PubMed ID: 7527980
[No Abstract] [Full Text] [Related]
6. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma.
Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y
Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma in cirrhosis: locoregional therapies for bridging to liver transplant.
Lee FT
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S24-6. PubMed ID: 17969066
[No Abstract] [Full Text] [Related]
9. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
10. Delayed anoxic pseudolobular necrosis (terminal hepatic necrosis) after chemo-lipiodolization for hepatocellular carcinoma.
Kozakai I; Ichida T; Yamaguchi O; Asakura H
Am J Gastroenterol; 1996 Jun; 91(6):1263-5. PubMed ID: 8651187
[No Abstract] [Full Text] [Related]
11. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
12. [-Comparison of lipiodol-assisted chemoembolization versus only conservative therapy in patients with nonresectable hepatocellular carcinomas-].
Lorenz M; Waldeyer M; Müller HH
Z Gastroenterol; 1996 Mar; 34(3):205-6. PubMed ID: 8650976
[No Abstract] [Full Text] [Related]
13. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma?
Moreno P; Jaurrieta E; Figueras J; Benasco C; Rafecas A; Fabregat J; Torras J; Casanovas T; Casais L
Transplant Proc; 1995 Aug; 27(4):2296-8. PubMed ID: 7652813
[No Abstract] [Full Text] [Related]
14. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
15. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
Trinchet JC; Mathieu D; Beaugrand M
Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406
[No Abstract] [Full Text] [Related]
16. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
[TBL] [Abstract][Full Text] [Related]
17. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis.
Hiraki T; Sakurai J; Gobara H; Kawamoto H; Mukai T; Hase S; Iguchi T; Fujiwara H; Tajiri N; Shiratori Y; Kanazawa S
J Vasc Interv Radiol; 2006 Mar; 17(3):583-5. PubMed ID: 16567686
[No Abstract] [Full Text] [Related]
18. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
[TBL] [Abstract][Full Text] [Related]
19. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
20. Preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Kobayashi T; Teruya M
Ann Surg; 2010 Feb; 251(2):386; author reply 386-7. PubMed ID: 20040849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
